Neurocrine Biosciences Statistics
NASDAQ: NBIXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
140.84-2.63 (-1.83%)
Market open · Delayed 15 min · as of Oct 8, 12:41 PM ET
Neurocrine Biosciences by the numbers
Neurocrine Biosciences has a market capitalization of $14.32 billion based on 101.65M shares outstanding. Its trailing P/E ratio is 20.7, below the 5-company peer median of 40.4, and its forward P/E is 11.9. The stock trades 8.3% below its 50-day average and 4.4% below its 200-day average.
Average daily trading volume is 1.30M shares, or about $182.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NBIX valuation vs. peer median
| Metric | NBIX | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.32B | $10.24B | +40% |
| P/E (TTM) | 20.7 | 40.4 | -49% |
| Forward P/E | 11.9 | 31.3 | -62% |
| Avg. volume | 1.30M | 2.08M | -38% |
Peer median across 8 companies: EXEL, HALO, TECH, IBRX, RGEN, TWST, PCVX, KRYS.
Valuation
- Market cap
- $14.32B
- P/E (TTM)
- 20.65
- Forward P/E
- 11.86
- Price / sales (latest FY)
- 5.00
- EPS (TTM)
- $6.82
- Shares outstanding
- 101.65M
Price and trading
- Previous close
- 143.47
- Open
- 142.88
- Day range
- 140.34 – 143.02
- 52-week range
- 122.14 – 186.12
- 52-week change
- +4.72%
- 50-day moving average
- 153.62
- 200-day moving average
- 147.28
- Beta
- —
- Volume
- 329.39K
- Average volume
- 1.30M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 14.32B
- Pe
- 20.65
- Forward Pe
- 11.86
- Eps
- 6.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 186.12
- Week52 Low
- 122.14
- Avg Volume
- 1.30M
- Shares Outstanding
- 101.65M
- Ma50
- 153.62
- Ma200
- 147.28
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -24.33%
- Pct From52w Low
- 15.31%